Cardio Intelligence
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cardio Intelligence - overview
Established
2019
Location
Tokyo, -, Japan
Primary Industry
Healthcare IT
About
Based in Tokyo, Japan, and founded in 2019, Cardio Intelligence Inc. engages in research, develops, and sells automatic diagnosis systems that utilize artificial intelligence technology. The company delivers arrhythmia diagnostics worldwide through AI, Cardio Intelligence leverages vast ECG data and expert annotations to build high-precision AI solutions. In March 2026, Cardio Intelligence raised an undisclosed amount in series B funding from Altomos Investment Co.
, Ltd. The company’s flagship product, the SmartRobin AI Series, is a long-term ECG analysis software that automatically detects atrial fibrillation with high accuracy. This series also includes explainable AI to aid non-cardiology specialists in making definitive diagnoses and pre-disease diagnostic AI that detects atrial fibrillation signs during non-attack periods, a technology for which it has filed a patent. The company plans to use its proceeds from November 2025 funding for product development, enhancing its internal framework and international expansion.
Current Investors
Daiwa Corporate Investment, SMBC Venture Capital, M3, Inc.
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Diagnostic Equipment, Medical Software
Website
www.cardio-i.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Cardio Intelligence - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.